- Home
- COOP vs NBIX Comparison
COOP vs NBIX Comparison
Compare COOP & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOP
- NBIX
- Stock Information
- Founded
- COOP 1994
- NBIX 1992
- Country
- COOP United States
- NBIX United States
- Employees
- COOP N/A
- NBIX N/A
- Industry
- COOP Finance: Consumer Services
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- COOP Finance
- NBIX Health Care
- Exchange
- COOP Nasdaq
- NBIX Nasdaq
- Market Cap
- COOP 12.3B
- NBIX 14.1B
- IPO Year
- COOP N/A
- NBIX 1996
- Fundamental
- Price
- COOP $220.90
- NBIX $142.73
- Analyst Decision
- COOP Buy
- NBIX Strong Buy
- Analyst Count
- COOP 9
- NBIX 18
- Target Price
- COOP $140.13
- NBIX $161.50
- AVG Volume (30 Days)
- COOP 746.6K
- NBIX 739.8K
- Earning Date
- COOP 10-22-2025
- NBIX 10-29-2025
- Dividend Yield
- COOP N/A
- NBIX N/A
- EPS Growth
- COOP N/A
- NBIX 2.97
- EPS
- COOP 8.75
- NBIX 3.39
- Revenue
- COOP $2,246,000,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- COOP $12.76
- NBIX $20.66
- Revenue Next Year
- COOP $10.84
- NBIX $14.64
- P/E Ratio
- COOP $24.70
- NBIX $42.27
- Revenue Growth
- COOP 5.69
- NBIX 18.42
- 52 Week Low
- COOP $84.68
- NBIX $84.23
- 52 Week High
- COOP $234.73
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- COOP 68.33
- NBIX 59.60
- Support Level
- COOP $210.29
- NBIX $139.25
- Resistance Level
- COOP $226.65
- NBIX $144.04
- Average True Range (ATR)
- COOP 9.87
- NBIX 3.57
- MACD
- COOP 0.84
- NBIX -0.16
- Stochastic Oscillator
- COOP 76.45
- NBIX 69.94
About COOP Mr. Cooper Group Inc.
Mr. Cooper Group Inc is a home loan servicer. The company focuses on delivering a variety of servicing and lending products. It has operating segments namely Servicing segment which performs operational activities on behalf of investors or owners of the underlying mortgages and mortgage servicing rights, including collecting and disbursing borrower payments, investor reporting, and customer service, The Originations segment originates residential mortgage loans through a direct-to-consumer channel, which provides refinance options for existing customers, and through a correspondent channel, which purchases or originates loans from mortgage bankers and brokers, and the Corporate segment. The Servicing segment of the company generates maximum revenue.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.